EE200000481A - A pharmaceutical preparation containing angiotensin II type 2 receptor agonist and its use - Google Patents
A pharmaceutical preparation containing angiotensin II type 2 receptor agonist and its useInfo
- Publication number
- EE200000481A EE200000481A EEP200000481A EEP200000481A EE200000481A EE 200000481 A EE200000481 A EE 200000481A EE P200000481 A EEP200000481 A EE P200000481A EE P200000481 A EEP200000481 A EE P200000481A EE 200000481 A EE200000481 A EE 200000481A
- Authority
- EE
- Estonia
- Prior art keywords
- type
- pharmaceutical preparation
- receptor agonist
- preparation containing
- containing angiotensin
- Prior art date
Links
- 102000025309 Type 2 Angiotensin Receptor Human genes 0.000 title 1
- 108010062475 Type 2 Angiotensin Receptor Proteins 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9800550A SE9800550D0 (en) | 1998-02-24 | 1998-02-24 | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
| PCT/SE1999/000262 WO1999043339A1 (en) | 1998-02-24 | 1999-02-24 | A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200000481A true EE200000481A (en) | 2002-02-15 |
Family
ID=20410283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200000481A EE200000481A (en) | 1998-02-24 | 1999-02-24 | A pharmaceutical preparation containing angiotensin II type 2 receptor agonist and its use |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1066048A1 (en) |
| JP (1) | JP2002504516A (en) |
| KR (1) | KR20010041211A (en) |
| CN (1) | CN1291104A (en) |
| AU (1) | AU755949B2 (en) |
| BR (1) | BR9908188A (en) |
| CA (1) | CA2319123A1 (en) |
| EE (1) | EE200000481A (en) |
| HU (1) | HUP0101411A3 (en) |
| ID (1) | ID26639A (en) |
| IL (1) | IL137990A0 (en) |
| IS (1) | IS5594A (en) |
| MX (1) | MXPA00008172A (en) |
| NO (1) | NO20004215L (en) |
| NZ (1) | NZ506188A (en) |
| SE (1) | SE9800550D0 (en) |
| SK (1) | SK11522000A3 (en) |
| WO (1) | WO1999043339A1 (en) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1793101A (en) * | 1999-12-16 | 2001-06-25 | University Of Southern California | Methods for treating and preventing damage to mucosal tissue |
| US6821953B1 (en) | 1999-12-16 | 2004-11-23 | University Of Southern California | Methods for treating and preventing damage to mucosal tissue |
| CA2449150C (en) | 2001-05-31 | 2011-07-12 | Vicore Pharma Ab | Tricyclic compounds useful as angiotensin ii agonists |
| ES2582945T3 (en) | 2005-04-12 | 2016-09-16 | Vicore Pharma Ab | New bicyclic agonists of angiotensin II |
| AU2006235698B2 (en) | 2005-04-12 | 2012-03-29 | Vicore Pharma Ab | New tricyclic angiotensin II agonists |
| JP5289043B2 (en) | 2005-04-12 | 2013-09-11 | ヴィコール・ファルマ・アーベー | Novel tricyclic angiotensin II agonist |
| DK1968635T3 (en) * | 2005-12-14 | 2014-12-15 | Ambrx Inc | Compositions and Methods of, and uses of non-natural amino acids and polypeptides |
| US8835471B2 (en) | 2010-06-11 | 2014-09-16 | Vicore Pharma Ab | Use of angiotensin II agonists |
| EP2455388A1 (en) | 2010-11-23 | 2012-05-23 | LanthioPep B.V. | Novel angiotensin type 2 (AT2) receptor agonists and uses thereof. |
| WO2013158628A1 (en) * | 2012-04-16 | 2013-10-24 | New York University | Modulation of angiotensin ii peceptors for the prevention and treatment of cerebral malaria |
| CN107405406A (en) | 2015-03-02 | 2017-11-28 | 维科尔药物公司 | Angiotensin II receptor agonists for the treatment of pulmonary fibrosis |
| WO2017221012A1 (en) | 2016-06-21 | 2017-12-28 | Vicore Pharma Ab | Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity |
| GB201818164D0 (en) | 2018-11-07 | 2018-12-19 | Vicore Pharma Ab | New composition |
| WO2021023698A1 (en) | 2019-08-02 | 2021-02-11 | Lanthiopep B.V | Angiotensin type 2 (at2) receptor agonists for use in the treatment of cancer |
| GB201913603D0 (en) | 2019-09-20 | 2019-11-06 | Vicore Pharma Ab | New compounds |
| KR20230004501A (en) | 2020-03-19 | 2023-01-06 | 바이코어 파마 아베 | New Compounds Useful for the Treatment and/or Prevention of Diseases, Disorders, or Conditions Associated with Angiotensin II |
| GB202004094D0 (en) | 2020-03-20 | 2020-05-06 | Vicore Pharma Ab | New compounds and uses |
| GB202006079D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202006081D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202006074D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202013721D0 (en) | 2020-09-01 | 2020-10-14 | Vicore Pharma Ab | New compounds |
| GB202104038D0 (en) | 2021-03-23 | 2021-05-05 | Vicore Pharma Ab | New compounds |
| GB202104033D0 (en) | 2021-03-23 | 2021-05-05 | Vicore Pharma Ab | New compounds |
| EP4313953A1 (en) | 2021-03-23 | 2024-02-07 | Vicore Pharma AB | Selective angiotensin ii receptor ligands |
| MX2024000518A (en) | 2021-07-09 | 2024-01-31 | Vicore Pharma Ab | New selective angiotensin ii compounds. |
| GB202115303D0 (en) | 2021-10-25 | 2021-12-08 | Vicore Pharma Ab | New formulation |
| GB202201723D0 (en) | 2022-02-10 | 2022-03-30 | Vicore Pharma Ab | New use |
| WO2023152503A1 (en) | 2022-02-10 | 2023-08-17 | Vicore Pharma Ab | Use of buloxibutid for the treatment of idiopathic pulmonary fibrosis |
| CA3247073A1 (en) | 2022-04-06 | 2025-02-03 | Wuhan Humanwell Innovative Drug Research and Development Center Limited Company | At2r agonist |
| IE20230600A3 (en) | 2022-12-22 | 2025-09-24 | Vicore Pharma Ab | A method of treating a patient diagnosed with an interstitial lung disease |
| WO2024149712A1 (en) | 2023-01-09 | 2024-07-18 | Vicore Pharma Ab | Selective angiotensin ii compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5444067A (en) * | 1993-08-30 | 1995-08-22 | Merck & Co., Inc. | Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety |
| WO1996014060A1 (en) * | 1994-11-04 | 1996-05-17 | Marklund Stefan L | Use of receptor agonists to stimulate superoxide dismutase activity |
| SE9501881D0 (en) * | 1995-05-19 | 1995-05-19 | Astra Ab | New pharmacological use of AII receptor antagonists |
| US5834432A (en) * | 1995-06-06 | 1998-11-10 | The University Of Southern California | Use of angiotensin II Type 2 receptor agonists in tissue repair |
| SE9502219D0 (en) * | 1995-06-19 | 1995-06-19 | Astra Ab | Novel medical use |
-
1998
- 1998-02-24 SE SE9800550A patent/SE9800550D0/en unknown
-
1999
- 1999-02-24 BR BR9908188-1A patent/BR9908188A/en not_active IP Right Cessation
- 1999-02-24 EE EEP200000481A patent/EE200000481A/en unknown
- 1999-02-24 ID IDW20001909A patent/ID26639A/en unknown
- 1999-02-24 IL IL13799099A patent/IL137990A0/en unknown
- 1999-02-24 JP JP2000533135A patent/JP2002504516A/en active Pending
- 1999-02-24 NZ NZ506188A patent/NZ506188A/en unknown
- 1999-02-24 MX MXPA00008172A patent/MXPA00008172A/en unknown
- 1999-02-24 WO PCT/SE1999/000262 patent/WO1999043339A1/en not_active Ceased
- 1999-02-24 CN CN99803230A patent/CN1291104A/en active Pending
- 1999-02-24 HU HU0101411A patent/HUP0101411A3/en unknown
- 1999-02-24 CA CA002319123A patent/CA2319123A1/en not_active Abandoned
- 1999-02-24 KR KR1020007009295A patent/KR20010041211A/en not_active Withdrawn
- 1999-02-24 SK SK1152-2000A patent/SK11522000A3/en unknown
- 1999-02-24 EP EP99908017A patent/EP1066048A1/en not_active Withdrawn
- 1999-02-24 AU AU27537/99A patent/AU755949B2/en not_active Ceased
-
2000
- 2000-08-21 IS IS5594A patent/IS5594A/en unknown
- 2000-08-23 NO NO20004215A patent/NO20004215L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0101411A2 (en) | 2002-03-28 |
| NO20004215L (en) | 2000-09-18 |
| CA2319123A1 (en) | 1999-09-02 |
| AU755949B2 (en) | 2003-01-02 |
| CN1291104A (en) | 2001-04-11 |
| EP1066048A1 (en) | 2001-01-10 |
| KR20010041211A (en) | 2001-05-15 |
| IS5594A (en) | 2000-08-21 |
| JP2002504516A (en) | 2002-02-12 |
| WO1999043339A1 (en) | 1999-09-02 |
| NZ506188A (en) | 2003-04-29 |
| HUP0101411A3 (en) | 2002-11-28 |
| SK11522000A3 (en) | 2001-04-09 |
| BR9908188A (en) | 2000-10-24 |
| AU2753799A (en) | 1999-09-15 |
| IL137990A0 (en) | 2001-10-31 |
| SE9800550D0 (en) | 1998-02-24 |
| ID26639A (en) | 2001-01-25 |
| MXPA00008172A (en) | 2002-06-21 |
| NO20004215D0 (en) | 2000-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200000481A (en) | A pharmaceutical preparation containing angiotensin II type 2 receptor agonist and its use | |
| EE04144B1 (en) | A pharmaceutical composition and its use | |
| EE200000468A (en) | The compounds, their use and the pharmaceutical composition | |
| PT1019358E (en) | 3,3-DIARILPROPILLAMINES ITS USE AND PREPARATION | |
| FI19992801L (en) | NMDA receptor 1-aminoalkylcyclohexane antagonists | |
| PT1177178E (en) | SUBSTITUTED HETERICYLIC BENZIMIDAZOES, THEIR PREPARATION AND APPLICATION | |
| NO20012915L (en) | New pharmaceutical formulation | |
| DE69916922D1 (en) | Medicinal preparation containing ibuprofen | |
| PT1123274E (en) | SUBSTITUTED PHENYLENE DERIVATIVES, ITS PREPARATION AND UTILIZATION | |
| BR9708400A (en) | Composition, preparation and use | |
| NO20012411D0 (en) | Pyrrolidine derivatives-CCR-3 receptor antagonists | |
| BRPI9810519B1 (en) | 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives and pharmaceutical composition comprising the same. | |
| EE04452B1 (en) | Pharmaceutically Active Morpholinol and Its Use | |
| ID29247A (en) | RETINOID RECEPTOR FUNCTION MATERIALS | |
| PT1073672E (en) | ANTI-PICORNAVIRUS COMPOUNDS, THEIR PREPARATION AND UTILIZATION | |
| ATE432707T1 (en) | PHARMACEUTICAL PREPARATION | |
| ID24726A (en) | TROMBIN RECEPTOR ANTAGONISTS | |
| NO20010089D0 (en) | Pharmaceutical levothyroxine preparation | |
| ID24162A (en) | VITRONECTTIN RECEPTOR ANTAGONISTS | |
| IT1292461B1 (en) | PHOTOCROMATIC COMPOUNDS, PROCEDURE FOR THEIR PREPARATION AND THEIR USE IN POLYMERIC MATERIALS | |
| GB9820014D0 (en) | Receptor antagonists and uses thereof | |
| EE03387B1 (en) | Combined pharmaceutical preparation, its use and method for its preparation | |
| EE04260B1 (en) | Pharmaceutical composition, process for its preparation and use | |
| AU5861900A (en) | Receptor agonists and antagonists | |
| BR9710568A (en) | Pharmaceutical composition containing a 5Hht2c antagonist and a d2 antagonist |